New hope to cut opioid dependence for sickle cell patients in agony

NCT ID NCT07274254

Summary

This study aims to see if adding the numbing medication lidocaine to standard pain care can help adults with sickle cell disease use fewer opioid painkillers during severe pain crises. It will involve 104 adults admitted to the intensive care unit for these crises. The main goal is to measure if the total amount of opioids needed is lower when lidocaine is added to their treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHRU Tours - Hôpital Bretonneau

    Tours, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Bordeaux

    Bordeaux, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Guadeloupe

    Les Abymes, Guadeloupe

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU La Timone

    Marseille, France

  • CHU Lille

    Lille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Orléans

    Orléans, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Poitiers

    Poitiers, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Rouen

    Rouen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de Nantes

    Nantes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Tenon APHP

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Oncopole Toulouse

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.